Body weight, age, and sex Your body size, age, and sex can change how semaglutide is absorbed and used
You may not even know exactly what youre getting or whether the dose is accurate from one administration to the next. Indeed, GLP-1 use without medical oversight heightens the risk of medication side effects, such as gallbladder disease, pancreatitis, thyroid conditions, retinopathy and nutrient deficiencies
In the Phase IV study, semaglutide will be evaluated for its effects on improving depressive symptoms over 26 weeks in patients with major depressive disorder who also have overweight or obesity ( ID NCT07136714)
2024:dc231450
Clinical studies, including the STEP 1 extension trial with semaglutide 2.4 mg, have shown that patients often regain a significant proportion of weight lost during GLP-1 therapy, typically over several months
Consistency matters more than perfection